Ofloskat Eye Drop is a sterile ophthalmic solution containing Ofloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic, and Ketorolac 0.5% w/v, a nonsteroidal anti-inflammatory drug (NSAID). This combination is indicated for the treatment of bacterial ocular infections accompanied by inflammation and pain. Ofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible gram-positive and gram-negative pathogens. Ketorolac provides potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, reducing the synthesis of prostaglandins responsible for inflammation and pain. Ofloskat Eye Drop is commonly prescribed for bacterial conjunctivitis, keratitis, and postoperative ocular inflammation where infection and inflammation coexist. The formulation ensures rapid relief from symptoms such as redness, swelling, and discomfort while addressing the underlying infection. It is recommended to be used as directed by an ophthalmologist, typically instilled into the affected eye(s) several times daily. Caution is advised in patients with hypersensitivity to fluoroquinolones or NSAIDs. Proper administration and adherence to the prescribed regimen are essential to achieve optimal therapeutic outcomes and prevent resistance development.